SCHEMBL6358526

SCHEMBL6358526

COC(=O)c1cccc(C(=O)c2cccc(C(=O)Nc3ccc(Cl)cc3C(=O)O)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 11/20 0.67
AKR1C4 P17516 1/20 0.67
AKR1C3 P42330 1/20 0.67
AKR1C2 P52895 1/20 0.67
AKR1C1 Q04828 1/20 0.67
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
GFER P55789 1/20 0.57
KDM4E B2RXH2 2/20 0.57
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
MAPT P10636 1/20 0.54
PKM P14618 1/20 0.52
HSD17B10 Q99714 1/20 0.52
GRIK1 P39086 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352878 0.95 SERPINE1 (0.76) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6349319 0.89 SERPINE1 (0.85) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6351306 0.88 SERPINE1 (0.82) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6353180 0.87 SERPINE1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6353650 0.87 MEN1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6352349 0.85 SERPINE1 (0.61) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6352179 0.84 SERPINE1 (0.63) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6359691 0.83 SERPINE1 (0.71) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6357753 0.83 SERPINE1 (0.67) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL6346671 0.83 SERPINE1 (0.70) SERPINE1AKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885AKR1C4 3065/4885AKR1C3 3288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.